CSIMarket
 
Panacea Life Sciences Holdings Inc   (EXDI)
Other Ticker:  
 
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 17
 Employees -
 Revenues (TTM) (Millions $) 2
 Net Income (TTM) (Millions $) -8
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Panacea Life Sciences Holdings Inc
Panacea Life Sciences Holdings Inc is a company that specializes in the research, development, and production of CBD products. They are committed to providing high-quality, all-natural CBD solutions for health and wellness. With advanced extraction and purification techniques, they are able to create pure CBD products that offer therapeutic benefits. Panacea Life Sciences Holdings Inc is focused on improving the lives of individuals by offering a diverse range of CBD products for various health conditions.


   Company Address: 5910 S University Blvd Greenwood Village 80121 CO
   Company Phone Number: 985-0515   Stock Exchange / Ticker: EXDI
   EXDI is expected to report next financial results on March 29, 2024.


Customers Net Income grew by EXDI's Customers Net Profit Margin grew to

3273.4 %

2.26 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BA   -2.39%    
DISH        15.4% 
GD        1.07% 
LDOS   -0.7%    
LMT   -0.39%    
NOC        0.77% 
• View Complete Report
   



Panacea Life Sciences Holdings Inc

Panacea Life Sciences Holdings Inc: Revenue Recedes, But Promising Implications Emerge for Future Growth



Panacea Life Sciences Holdings Inc recently released their financial results for the fiscal time-frame ending September 30, 2023. While the company witnessed a loss in earnings compared to the previous year and quarter, there are several noteworthy aspects that may have significant implications for the company's future. This article aims to interpret these results and explore how they might impact the company moving forward.
1. Decreasing Losses Per Share:
Panacea Life Sciences Holdings Inc managed to reduce their losses per share from $-0.18 to $-0.13 compared to the previous year. Although they still reported a loss, this improvement signifies progress in managing the company's financial performance.

Panacea Life Sciences Holdings Inc

Panacea Life Sciences Holdings Inc. Reports Sharp Decline in Revenue as Deficit Swells in First Quarter of 2023

Panacea Life Sciences Holdings Inc., a pharmaceutical company, has recently released its financial report for the first quarter of 2023. According to the report, the company's deficit has swelled by $-0.12 per share, as compared to $0.31 a year ago. However, the EPS (Earnings Per Share) has improved from $-0.18 per share from the prior reporting period.
In terms of revenue, the company has witnessed a decline of -41.5% to $0.68 million as compared to $1.16 million in the corresponding reporting period a year ago. However, sequentially, revenue surged by 84.981% from $0.37 million. The company's net deficit for the first quarter of 2023 stood at $-1.791 million, instead of the bottom line of $3.287 million achieved in the corresponding reporting period a year before.






 

Panacea Life Sciences Holdings Inc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com